UBS Group’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Buy |
15,701
+12,721
| +427% | +$17.8K | ﹤0.01% | 7058 |
|
|
2025
Q1 | $5.28K | Sell |
2,980
-4,271
| -59% | -$7.56K | ﹤0.01% | 7701 |
|
|
2024
Q4 | $16.7K | Buy |
+7,251
| New | +$16.7K | ﹤0.01% | 6764 |
|
|
2024
Q3 | – | Sell |
-3,145
| Closed | -$8.71K | – | 8905 |
|
|
2024
Q2 | $8.71K | Buy |
3,145
+3,052
| +3,282% | +$8.45K | ﹤0.01% | 6629 |
|
|
2024
Q1 | $617 | Sell |
93
-2,051
| -96% | -$13.6K | ﹤0.01% | 7268 |
|
|
2023
Q4 | $6.54K | Buy |
+2,144
| New | +$6.54K | ﹤0.01% | 6485 |
|
|
2023
Q3 | – | Sell |
-1,357
| Closed | -$2.43K | – | 8774 |
|
|
2023
Q2 | $2.43K | Buy |
1,357
+1,257
| +1,257% | +$2.25K | ﹤0.01% | 6670 |
|
|
2023
Q1 | $124 | Sell |
100
-3,212
| -97% | -$3.98K | ﹤0.01% | 8101 |
|
|
2022
Q4 | $7.85K | Buy |
3,312
+3,212
| +3,212% | +$7.61K | ﹤0.01% | 7659 |
|
|
2022
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 9800 |
|
|
2022
Q2 | $1K | Sell |
100
-456
| -82% | -$4.56K | ﹤0.01% | 8957 |
|
|
2022
Q1 | $6K | Sell |
556
-612
| -52% | -$6.6K | ﹤0.01% | 7955 |
|
|
2021
Q4 | $13K | Buy |
1,168
+784
| +204% | +$8.73K | ﹤0.01% | 7358 |
|
|
2021
Q3 | $8K | Sell |
384
-201
| -34% | -$4.19K | ﹤0.01% | 7086 |
|
|
2021
Q2 | $15K | Buy |
585
+476
| +437% | +$12.2K | ﹤0.01% | 6559 |
|
|
2021
Q1 | $3K | Buy |
+109
| New | +$3K | ﹤0.01% | 7498 |
|
|
2020
Q4 | – | Sell |
-264
| Closed | -$7K | – | 7694 |
|
|
2020
Q3 | $7K | Sell |
264
-768
| -74% | -$20.4K | ﹤0.01% | 6268 |
|
|
2020
Q2 | $24K | Buy |
+1,032
| New | +$24K | ﹤0.01% | 5598 |
|
|
2020
Q1 | – | Sell |
-167
| Closed | -$2K | – | 7282 |
|
|
2019
Q4 | $2K | Buy |
+167
| New | +$2K | ﹤0.01% | 6779 |
|
|
2019
Q2 | – | Sell |
-100
| Closed | -$4K | – | 7185 |
|
|
2019
Q1 | $4K | Buy |
+100
| New | +$4K | ﹤0.01% | 6440 |
|
|
2018
Q4 | – | Sell |
-218
| Closed | -$12K | – | 7259 |
|
|
2018
Q3 | $12K | Buy |
218
+215
| +7,167% | +$11.8K | ﹤0.01% | 6162 |
|
|
2018
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 7199 |
|
|
2018
Q1 | – | Sell |
-88
| Closed | -$18K | – | 7101 |
|
|
2017
Q4 | $18K | Buy |
88
+30
| +52% | +$6.14K | ﹤0.01% | 5670 |
|
|
2017
Q3 | $16K | Buy |
+58
| New | +$16K | ﹤0.01% | 5707 |
|